Viking Therapeutics
VKTX
#2494
Rank
โ‚น494.37 B
Marketcap
โ‚น4,436
Share price
1.86%
Change (1 day)
333.62%
Change (1 year)

Revenue for Viking Therapeutics (VKTX)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Viking Therapeutics from 2014 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น40.60 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น6.35 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น50.81 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA